MatthewDanielStachlerMDPh.D.

PubMed

• Refining definitions of Barrett's oesophagus to improve clinical resource utilisation.
  Matthew D Stachler, Qurat Ul Ain> ;Gut. 2024 Apr 5
• Feasibility Study Utilizing NanoString's Digital Spatial Profiling (DSP) Technology for Characterizing the Immune Microenvironment in Barrett's Esophagus Formalin-Fixe...
  Qurat-Ul-Ain, Frei, N., Khoshiwal, A., Stougie, P., Camilleri-Broet, S., Ferri, L., Duits, L., Bergman, J., Odze, R., Stachler, M.> ;Cancers. 2023 Dec 18
• 3 citations
  Genomic signatures of past and present chromosomal instability in Barrett's esophagus and early esophageal adenocarcinoma.
  Stachler, M. D., Stachler, M. D., Chunyang Bao, Richard W Tourdot, Gregory J Brunette, Chip Stewart, Lili Sun, Hideo Baba, Masayuki Watanabe, Agoston T Agoston, Kunal ...> ;Nature Communications. 2023 Oct 4
• TSP-9: A Barrett's Esophagus Biomarker Better Than Pathologists?
  Joel H Rubenstein, Matthew D Stachler> ;Gastroenterology. 2023 Nov 1
• Bridging the Gap between Diseases of the Stomach and Lower Esophagus.
  Matthew D Stachler> ;Cancer Discovery. 2023 Jun 2
• Degree of crypt atypia correlates with progression to high-grade dysplasia/adenocarcinoma in non-dysplastic Barrett's oesophagus.
  Robert Odze, Nicola Frei, Amir M Khoshiwal, Lucas C Duits, Jacques Bergman, Matthew D Stachler> ;Histopathology. 2023 Sep 1
• 1 citations
  Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights.
  Annesha Chatterjee, Jordana Maria Azevedo-Martins, Matthew D Stachler> ;Oncotargets and Therapy. 2023 Jan 1
• 1 citations
  Today's Mistakes and Tomorrow's Wisdom in Development and Use of Biomarkers for Barrett's Esophagus.
  Nicola F Frei, Matthew D Stachler> ;Visceral Medicine. 2022 Jun 1
• 28 citations
  Abnormal TP53 Predicts Risk of Progression in Patients With Barrett's Esophagus Regardless of a Diagnosis of Dysplasia.
  Mark Redston, Amy Noffsinger, Anthony Kim, Fahire G Akarca, Marianne Rara, Diane Stapleton, Laurel Nowden, Richard H. Lash, Adam J. Bass, Matthew D. Stachler> ;Gastroenterology. 2021 Oct 29
• 2 citations
  Molecular Pathology of Gastroesophageal Cancer.
  Matthew D. Stachler, Ramon U Jin> ;Surgical Pathology Clinics. 2021 Jul 8
• Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic charact...
  Panieh Terraf, Lynette M. Sholl, Matthew S. Davids, Mark M. Awad, Elizabeth P. Garcia, Laura E. MacConaill, Paola Dal Cin, Annette S. Kim, Neal I. Lindeman, Matthew D....> ;Cold Spring Harbor Molecular Case Studies. 2021 Jun 1
• 35 citations
  Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence.
  Zhong Wu, Jin Zhou, Xiaoyang Zhang, Zhouwei Zhang, Yingtian Xie, Jie Bin Liu, Zandra V. Ho, Arpit Panda, Xintao Qiu, Paloma Cejas, Israel Cañadas, Fahire G Akarca, Jam...> ;Nature Genetics. 2021 May 10
• 2 citations
  Can Genomic Sequencing Identify High-Risk Barrett’s Esophagus Earlier Than Pathologists?
  Matthew D. Stachler, Adam J. Bass> ;Cancer Cell. 2020 Nov 9
• 79 citations
  Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.
  Uppaluri, R., Campbell, K., Egloff, A., Zolkind, P., Skidmore, Z., Nussenbaum, B., Paniello, R., Rich, J., Jackson, R., Pipkorn, P., Michel, L., Ley, J., Oppelt, P., D...> ;Clinical Cancer Research. 2020 Oct 1
• 32 citations
  Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model
  Nilay Sethi, Osamu Kikuchi, Gina N. Duronio, Matthew D. Stachler, James M. McFarland, Ruben Ferrer-Luna, Yanxi Zhang, Chunyang Bao, Roderick T. Bronson, Deepa T. Patil...> ;Nature Genetics. 2020 Feb 5
• 67 citations
  Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer
  Haisheng Zhang, Antje Schaefer, Yichen Wang, Richard G. Hodge, Devon R. Blake, J. Nathaniel Diehl, Alex G. Papageorge, Matthew D. Stachler, Jennifer Liao, Jin Zhou, Zh...> ;Cancer Discovery. 2020 Feb 1
• 7 citations
  Risk stratification in Barrett's esophagus patients with diagnoses of indefinite for dysplasia: the definite silver bullet has not (yet) been found.
  Nicola Frei, Matthew D. Stachler, Jacques J. Bergman> ;Gastrointestinal Endoscopy. 2020 Jan 1
• 10 citations
  Clinicopathologic and genetic characteristics of interval colorectal carcinomas favor origin from missed or incompletely excised precursors.
  Thing Rinda Soong, Jennifer Nayor, Matthew D. Stachler, Molly Perencevich, Kunal Jajoo, John R. Saltzman, Neal I. Lindeman, Amitabh Srivastava> ;Modern Pathology. 2019 May 1
• Colorectal Adenocarcinoma, Not Just One Disease.
  Matthew D. Stachler> ;Cellular and Molecular Gastroenterology and Hepatology. 2019 Jan 1
• 10 citations
  Biomarkers for Barrett's esophagus - a contemporary review.
  Ali A Qureshi, Matthew D. Stachler, Omar J. Haque, Robert D. Odze> ;Expert Review of Molecular Diagnostics. 2018 Nov 1
• 27 citations
  Subtypes of Barrett’s oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis
  Ming Yu, Sean K. Maden, Matthew D. Stachler, Andrew M. Kaz, Jessica Ayers, Yuna Guo, Kelly T. Carter, Amber Willbanks, Tai J. Heinzerling, Rachele M. O'Leary, Xinsen X...> ;Gut. 2019 Mar 1
• 86 citations
  Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.
  Matthew D. Stachler, Nicholas D. Camarda, Christopher Deitrick, Anthony Kim, Agoston T. Agoston, Robert D. Odze, Jason L. Hornick, Anwesha Nag, Aaron R. Thorner, Matth...> ;Gastroenterology. 2018 Jul 1
• 32 citations
  Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocar...
  Melanie Johncilla, Matthew D. Stachler, Joseph Misdraji, Mikhail Lisovsky, Masato Yozu, Neal I. Lindeman, Gregory Y. Lauwers, Robert D. Odze, Amitabh Srivastava> ;Modern Pathology. 2018 Feb 8
• 210 citations
  Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
  Eirini Pectasides, Matthew D. Stachler, Sarah Derks, Yang Liu, Steven Brad Maron, Mirazul Islam, Lindsay Alpert, Heewon A. Kwak, Hedy L. Kindler, Blase N. Polite, Mani...> ;Cancer Discovery. 2018 Jan 1
• 50 citations
  CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma
  Jin Zhou, Zhong Wu, Gabrielle S. Wong, Eirini Pectasides, Ankur K. Nagaraja, Matthew D. Stachler, Haikuo Zhang, Ting Chen, Haisheng Zhang, Jie Bin Liu, Xinsen Xu, Ewa ...> ;Nature Communications. 2017 Jan 6
• Join now to see all

Journal Articles

• Clinicopathologic and Genetic Characteristics of Interval Colorectal Carcinomas Favor Origin from Missed or Incompletely Excised Precursors  
  John R Saltzman, Kunal Jajoo, Neal I Lindeman, Jennifer Nayor, Matthew D Stachler, Amitabh Srivastava, Molly Perencevich, Nature